These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38352564)

  • 21. The Fatty Acid Amide Hydrolase Inhibitor URB937 Ameliorates Radiation-Induced Lung Injury in a Mouse Model.
    Li R; Chen G; Zhou L; Xu H; Tang F; Lan J; Tong R; Deng L; Xue J; Lu Y
    Inflammation; 2017 Aug; 40(4):1254-1263. PubMed ID: 28478515
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Compound kushen injection suppresses human acute myeloid leukaemia by regulating the Prdxs/ROS/Trx1 signalling pathway.
    Jin Y; Yang Q; Liang L; Ding L; Liang Y; Zhang D; Wu B; Yang T; Liu H; Huang T; Shen H; Tu H; Pan Y; Wei Y; Yang Y; Zhou F
    J Exp Clin Cancer Res; 2018 Nov; 37(1):277. PubMed ID: 30454068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exploration of radiation-induced lung injury, from mechanism to treatment: a narrative review.
    Yan Y; Fu J; Kowalchuk RO; Wright CM; Zhang R; Li X; Xu Y
    Transl Lung Cancer Res; 2022 Feb; 11(2):307-322. PubMed ID: 35280316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Single-cell RNA-sequencing uncovers compound kushen injection synergistically improves the efficacy of chemotherapy by modulating the tumor environment of breast cancer.
    Liu X; Bai M; Li H; Ye P; Duan X; Wu C; Huang Z; Lu S; Zhang J; Zhao Z; Guo F; You R; Qin W; Wang W; Han A; Shen L; Wang Y; Zhao Z; Luo H; Wu J
    Front Immunol; 2022; 13():965342. PubMed ID: 36389835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exploring the pharmacological mechanism of compound kushen injection in the treatment of breast cancer using
    Ye Y; Zhang B; Liang Q; Wang D; Bai F; Li Y; Wei L; Li L; Huang H; Tang Y
    Front Oncol; 2022; 12():946758. PubMed ID: 36016606
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pirfenidone for the prevention of radiation-induced lung injury in patients with locally advanced oesophageal squamous cell carcinoma: a protocol for a randomised controlled trial.
    Chen C; Zeng B; Xue D; Cao R; Liao S; Yang Y; Li Z; Kang M; Chen C; Xu B
    BMJ Open; 2022 Oct; 12(10):e060619. PubMed ID: 36302570
    [TBL] [Abstract][Full Text] [Related]  

  • 27. α7‑nAchR agonist GTS‑21 reduces radiation‑induced lung injury.
    Mei Z; Tian X; Chen J; Wang Y; Yao Y; Li X; Yang C; Zhang S; Xie C
    Oncol Rep; 2018 Oct; 40(4):2287-2297. PubMed ID: 30106431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Re-Du-Ning injection ameliorates radiation-induced pneumonitis and fibrosis by inhibiting AIM2 inflammasome and epithelial-mesenchymal transition.
    Yang C; Song C; Wang Y; Zhou W; Zheng W; Zhou H; Deng G; Li H; Xiao W; Yang Z; Kong L; Ge H; Song Y; Sun Y
    Phytomedicine; 2022 Jul; 102():154184. PubMed ID: 35665679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protective Role of Nuclear Factor-Erythroid 2-Related Factor 2 Against Radiation-Induced Lung Injury and Inflammation.
    Tian X; Wang F; Luo Y; Ma S; Zhang N; Sun Y; You C; Tang G; Li S; Gong Y; Xie C
    Front Oncol; 2018; 8():542. PubMed ID: 30533397
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Compound Kushen Injection suppresses human breast cancer stem-like cells by down-regulating the canonical Wnt/β-catenin pathway.
    Xu W; Lin H; Zhang Y; Chen X; Hua B; Hou W; Qi X; Pei Y; Zhu X; Zhao Z; Yang L
    J Exp Clin Cancer Res; 2011 Oct; 30(1):103. PubMed ID: 22032476
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Compound Kushen Injection Induces Immediate Hypersensitivity Reaction Through Promoting the Production of Platelet-Activating Factor via
    Gao Y; Hai L; Kang Y; Qin W; Liu F; Cai R; Yang X; Qi Y
    Front Pharmacol; 2021; 12():768643. PubMed ID: 34690789
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An advanced network pharmacology study to explore the novel molecular mechanism of Compound Kushen Injection for treating hepatocellular carcinoma by bioinformatics and experimental verification.
    Lu S; Meng Z; Tan Y; Wu C; Huang Z; Huang J; Fu C; Stalin A; Guo S; Liu X; You L; Li X; Zhang J; Zhou W; Zhang X; Wang M; Wu J
    BMC Complement Med Ther; 2022 Mar; 22(1):54. PubMed ID: 35236335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of efficacy and safety for compound kushen injection combined with intraperitoneal chemotherapy for patients with malignant ascites: A systematic review and meta-analysis.
    Yu HB; Hu JQ; Han BJ; Cao HJ; Chen ST; Chen X; Xiong HT; Gao J; Du YY; Zheng HG
    Front Pharmacol; 2023; 14():1036043. PubMed ID: 36937874
    [No Abstract]   [Full Text] [Related]  

  • 34. Molecular Evidence of Compound Kushen Injection Against Lung Cancer: A Network Pharmacology-Based Investigation from Western Medicine to Traditional Medicine.
    Liang S; Li Y; Zhang X; Guo Y; Pan S
    Anticancer Agents Med Chem; 2021; 21(15):2012-2022. PubMed ID: 33573576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elucidating the pharmacological effects of Compound Kushen injection on MYC-P15-CCND1 signaling pathway in nasopharyngeal carcinoma - An in vitro study.
    Wu Z; Wu C; Shi J; Huang Z; Lu S; Tan Y; You R; Hai L; Huang J; Guo S; Gao Y; Jin Z; Tao X; You L; Wu J
    J Ethnopharmacol; 2023 Oct; 315():116702. PubMed ID: 37257705
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Compound Kushen Injection inhibits epithelial-mesenchymal transition of gastric carcinoma by regulating VCAM1 induced by the TNF signaling pathway.
    Huang Z; Wu C; Zhou W; Lu S; Tan Y; Wu Z; You R; Stalin A; Guo F; Zhang J; Liu P; Wang W; Duan X; You L; Wu J
    Phytomedicine; 2023 Sep; 118():154984. PubMed ID: 37487253
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dose-dependent induction of transforming growth factor beta (TGF-beta) in the lung tissue of fibrosis-prone mice after thoracic irradiation.
    Rube CE; Uthe D; Schmid KW; Richter KD; Wessel J; Schuck A; Willich N; Rube C
    Int J Radiat Oncol Biol Phys; 2000 Jul; 47(4):1033-42. PubMed ID: 10863076
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of GADD45a in murine models of radiation- and bleomycin-induced lung injury.
    Mathew B; Takekoshi D; Sammani S; Epshtein Y; Sharma R; Smith BD; Mitra S; Desai AA; Weichselbaum RR; Garcia JG; Jacobson JR
    Am J Physiol Lung Cell Mol Physiol; 2015 Dec; 309(12):L1420-9. PubMed ID: 26498248
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radioprotective efficacy of Astilbin in mitigating radiation-induced lung injury through inhibition of p53 acetylation.
    Liang L; Huang Y; Chen L; Shi Z; Wang H; Zhang T; Li Z; Mi J; Fan T; Lu Y; Chen F; Huang W; Hu K
    Environ Toxicol; 2023 Dec; 38(12):2967-2980. PubMed ID: 37598414
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in serum transforming growth factor-beta concentration as a predictive factor for radiation-induced lung injury onset in radiotherapy-treated patients with locally advanced lung cancer.
    Seto Y; Kaneko Y; Mouri T; Shimizu D; Morimoto Y; Tokuda S; Iwasaku M; Yamada T; Takayama K
    Transl Lung Cancer Res; 2022 Sep; 11(9):1823-1834. PubMed ID: 36248323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.